Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Diffusion Tensor Imaging × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 7 Breast 4 Gastrointestinal 2 Tumor-Agnostic 1 Thoracic 1 Sarcoma 1 Lymphoid 1 Gynecologic 1 Genitourinary 1

Conditions

Uterine Cervical Neoplasms 1

Interventions

Paclitaxel 498 Carboplatin 458 Cisplatin 303 Bevacizumab 218 pembrolizumab 201 Gemcitabine 129 Cyclophosphamide 113 Topotecan 107 olaparib 105 liposomal doxorubicin 104 Radiotherapy 98 Taxes 95 Docetaxel 83 Brachytherapy 80 Doxorubicin 76 Drug Therapy 71 niraparib 66 Nivolumab 64 Magnetic Resonance Spectroscopy 59 Specimen Handling 56 fludarabine 52 Biopsy 52 Hyperthermic Intraperitoneal Chemotherapy 45 Filgrastim 44 durvalumab 42 Letrozole 41 Platinum 39 Oxaliplatin 39 Radiation 38 atezolizumab 37

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01060033 2017-04-14

MRI

Washington University School of Medicine

Phase NA Completed

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡